公司資料
Indaptus Therapeutics 股價、新聞與催化劑
- 股票代碼:
- INDP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.00 USD (-6.54%)
收盤價
最後更新: 2026年8月17日
243M USD
市值
股價為何變動
As of Aug 17, 2026, INDP closed down 6.54% at $1.00. No new same-company headline was identified in the current news window.
公司概覽
Immunotherapy Research Company
Indaptus Therapeutics developed the Decoy platform, a systemic immunotherapy approach designed to activate multiple innate and adaptive immune pathways.
Decoy20
Decoy20 is a killed, attenuated bacterial product intended to stimulate broad antitumor immunity. Indaptus has discontinued enrollment and currently has no patients in active Decoy20 clinical studies.
Strategic Review
The company has reduced Decoy20 development activities and is evaluating research collaborations, strategic investments, acquisitions, and other potential business combinations.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。